Refine by
Clinical Data Technology Serving Belarus
17 companies found
Technologybased inSeattle, WASHINGTON (USA)
Headquartered in Seattle, Avaden Biosciences operates the largest human biosample network in the world. Our U.S.-based partnerships with over 200 CLIA/CAP accredited facilities provide immediate access to more than 35,000,000 highly annotated ...
Over 350 clinical data points per patient. Over 7,500 consented surgeries per month for custom tissue. Over 10,000 consented patients in ambulatory setting for blood draws. Fresh, FFPE, or frozen custom protocols - ...
Technologybased inJerusalem, ISRAEL
RenalSense is dedicated to real-time renal diagnostics. The company’s first product, Clarity RMS, is a critical care digital monitoring system for early detection of changes in renal function and acute kidney injury (AKI) risk. Continuous, ...
Clarity RMS™ is a critical care monitoring system that continuously measures urine flow, automatically transmitting to the medical staff real-time data, and notifications of fluctuations, on a 24/7 basis. This information, ...
Technologybased inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
DEPI matches these patient subgroups with an NDD-targeted drug (or drug combination) by integrating and analyzing large omics data sets, including genomics, proteomics, pharmacogenomics and clinical ...
Technologybased inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
Technologybased inStockholm, SWEDEN
RaySearch® is advancing cancer treatment through pioneering software. Software has unlimited potential, and it is now the driving force for innovation in oncology. Medical science never stands still and neither does RaySearch. We work in close ...
Save time and reduce the risk of error by automating treatment planning. Advanced plan-generating protocols, scripting, automated breast planning, fallback planning, machine learning and plan explorer are some of the tools available in ...
Technologybased inRaleigh, NORTH CAROLINA (USA)
Intelerad provides a range of products and technology to streamline the flow of information across healthcare departments and processes. Leveraging cloud and AI technology, their solutions enable independent reading groups, hospitals, radiology, and ...
A comprehensive image management suite designed for the modern researcher, featuring adaptable intake workflows, enhanced accessibility, and specialized tools to manage imaging research data. ...
Technologybased inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
Technologybased inViken, SWEDEN
TIKOMED AB is a privately owned company based in Viken, Sweden. It is governed by the Laws of the Kingdom of Sweden and was formed in accordance with the Swedish Company Act in 2002. We develop and commercialize innovative treatments for patients ...
ILB’s mechanism of action may either reduce the triggers that lead to cell death or prevent further pathology even if triggers are present. By addressing the underlying processes of disease, ILB could significantly improve outcomes for people ...
Technologybased inRegensburg, GERMANY
numares is an innovative diagnostics company. We focus on the discovery, development and commercialization of diagnostic tests, using metabolite constellations to solve unmet medical needs that could not be addressed by single biomarker-based ...
Development of chronic renal disease (chronic kidney disease; CKD) is a common consequence of many medical conditions, and its prevalence is rising. Predominant causes of CKD are hypertension and diabetes mellitus. Determination of ...
Technologybased inBasel, SWITZERLAND
Aurealis Therapeutics, a Swiss-Finnish private biopharmaceutical company, is now entering the clinical trial phase with its patented three-in-one combination product AUP-16 for chronic non-healing wounds and other regenerative diseases. The ...
Technologybased inPrinceton, NEW YORK (USA)
Geistlich Pharma North America brings the leader in regenerative dentistry directly to the United States and Canada. For 160 years, our respected family-owned Swiss parent company has pioneered technological advances that make regenerative ...
Technologybased inBradbury, CALIFORNIA (USA)
Biostrap is on a mission to provide the world’s most advanced, science-based platform to improve global health. Biostrap is the first affordable remote user monitoring platform utilizing advanced science-driven, Machine Learning/AI with ...
Technologybased inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
Increasingly, data are transforming our understanding of diseases. This is especially true in cancer. We have invested in robust data science capabilities to enable rapid data-driven decision making ...
Technologybased inEindhoven, NETHERLANDS
Xeltis is a clinical-stage medical device company pioneering a restorative approach in cardiovascular therapy. RestoreX™, Xeltis technology platform, is the world’s first polymer-based technology designed to enable natural restoration of ...
Endogenous Tissue Restoration (ETR) is a new therapeutic approach, enabling the patient’s own body to naturally restore a new blood vessel or heart valve. With ETR, the patient’s natural healing system develops tissue that pervades ...
Technologybased inSeattle, WASHINGTON (USA)
AVM Biotechnology is developing and advancing AVM0703, a proprietary formulation of concentrated dexamethasone. This formulation permits the very high dosing necessary to activate the release and trigger the production of the body’s supercharged ...
AVM0703 Induces & Mobilizes Gamma Delta+ NKT-Cells. AVM0703 triggers the production and release of gamma delta+ Natural Killer T-cells (AVM-NKT). These supercharged immune cells have unique properties and appear rapidly in the blood following a ...
Technologybased inVienna, AUSTRIA
Hookipa Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system. We are using our non-replicating and ...
Our scientific platform includes two distinct approaches to arenavirus-based therapies: replicating and non-replicating. Our replicating technology is designed to create a stronger immune response that we believe is more appropriate for use in ...
Technologybased inDijon, FRANCE
Oncodesign is a biopharmaceutical company that offers you powerful technologies and tools to guide you through the development of your drug, from medicinal chemistry to drug candidate. Our therapeutic areas are expanding. In addition to oncology, ...
This is the best tool you can use to evaluate new therapeutic approaches in conditions that are as close as possible to a clinical situation: ...